| Implementation | Reach | Adoption | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Site | Staff trained in roll-out period | Proportion of women with BP measurement pre-interventionψ | Proportion of women with BP measurement post-interventionψ | Unadjusted comparison | Facilities with working BP pre-intervention | Facilities with working BP post-intervention | Clinical areas using solely VSA at 6 months | Clinical areas using VSA with other devices at 6 months | Clinical areas using solely VSA at 12 months | Clinical areas using VSA with other devices at 12 months |
 | N (%) | N (%) | N (%) | OR (95% CI) | % (devices, HCP) | % (devices, HCP) | % | % | % | % |
Addis Ababa | 192 (36.9%) | * | * | * | 100% (1:3) | 100% (1:2) | 33.3% | 66.7% | Ï… | Ï… |
Cap Haitien | 189 (73.5%) | * | * | * | 100% (1:3) | 100% (1:3) | 76.2% | 23.8% | Ï… | Ï… |
Freetown | 243 (57.9%) | 2199 (87.7%) | 3335 (100%) | 1.14 (1.12–1.16) | 84·6% (1:13) | 100% (1:4) | 73.1% | 26.9% | 96.2% | 0.0% |
Gokak | 297 (87.1%) | * | * | * | 97·5% (1:1) | 100% (1:0.7) | 72.3% | 27.7% | υ | υ |
Harare | 405 (69.9%) | * | * | * | 92% (1:12) | 100% (1:5) | Ï… | Ï… | Ï… | Ï… |
Kampala | 188 (16.5%) | * | * | * | 92.3% (1:19) | 100% (1:4) | 33.8% | 47.9% | 34.2% | 47.9% |
Lusaka | 265 (33.9%) | * | * | * | 100% (1:10) | 100% (1:5) | 75.9% | 24.1% | Ï… | Ï… |
Mbale | 314 (59.2%) | 4640 (42.6%) | 11,300 (96.2%) | 2.26 (2.21–2.31) | 92% (1:5) | 100% (1:2) | 87.3% | 9.9% | υ | υ |
Ndola | 349 (86.6%) | 5673 (98.2%) | 5782 (100%) | 1.02 (1.0–1.2) | 93.5% (1:7) | 100% (1:2) | 90.2% | 9.8% | 90.2% | 9.8% |
Zomba | 305 (89.2%) | 11,860 (88.4%) | 10,783 (94.1%) | 1.06 (1.06–1.07) | 100% (1:17) | 100% (1:2) | υ | υ | υ | υ |
Total/Mean | 2747 (61.1%) | 6093 (79.2%) | 7800 (97.6%) | 1.30 (1.29–1.31) | 95% (1:9) | 100% (1:3) | 73.1% | 23.3% | 73.5% | 20.0% |